Search results for: Precision Medicine
Filter search results
Spotlight on OHE: Valuing Spillovers, End-of-Life Decisions and Hospital Outcomes
20 March 2012
…in all three of its main areas of research. The economic benefits of research on medicines, inside and outside the pharmaceutical industry, extend far beyond the development of important new…
New Research on VBP: Disease Severity and Unmet Need in the UK
24 April 2012
The UK Department of Health’s value based pricing (VBP) Consultation Document proposes a process whereby higher prices would be granted to medicines that tackle diseases that produce the greatest burdens…
The impact of inflation on incremental costs in HTA
4 June 2026
…of medicine itself, rise over time due to inflation. This pushes up the overall cost of providing new treatments when assessed by health technology appraisal bodies, even when the treatment’s own…
New OHE Consulting Report Explores the Many Faces of Innovation
19 June 2012
Now available from the OHE website, this report provides a clear explanation of the complex nature of innovation in medicines. A fully revised and expanded version of the 2005 edition…
Save the Date: Drug Development in 2022, OHE’s 50th Anniversary Conference
21 June 2012
…include: Dr Richard Barker, Director of the Centre for Accelerating Medical Innovations, University of Oxford Professor Sir Alasdair Breckenridge, Chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA)…
Register Now for the OHE Conference on Drug Development in 2022
2 July 2012
…Sir Alasdair Breckenridge, Chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA) Professor Patricia Danzon, The Wharton School, University of Pennsylvania Dr Hans-Georg Eichler, Senior Medical Officer, European…
Value Based Pricing in Sweden: Lessons for Design?
28 November 2012
…which is the health technology assessment (HTA) agency in Sweden. In Sweden, the TLV makes decisions on the reimbursement status of new medicines, under a system introduced in 2002. Its…
New Pilot Study: Capturing Public Preferences about Health Care Priorities
16 January 2013
The proposals from the UK Department of Health (DH) for value based pricing (VBP) include a process whereby higher prices would be granted to medicines that tackle the most burdensome…
OHE Welcomes Professors Rawlins and Smith to its Policy Board
6 May 2013
…Professor Sir Michael Rawlins, President of the Royal Society of Medicine, was chairman of the National Institute of Health and Clinical Excellence (NICE) from its formation in 1999 to April…